- Home
- J&J Innovative Medicine
J&J Innovative Medicine
Meet the Johnson & Johnson Scientist Who’s Helping to Fight Tropical Diseases in His Homeland
Two decades after leaving India, Anil Koul has returned to helm its Institute of Microbial Technology. For Dengue Awareness Month, we caught up with him to learn how he’s hoping to combat this tropical scourge and another disease that kills over a million worldwide.
This Is Your Brain With Schizophrenia: How the Illness Manifests and What Researchers Are Doing to Help
Thanks to cutting-edge innovations in imaging, adherence and early intervention, mental health researchers are making crucial advances in the understanding and management of the complex condition. We delve into their work for Mental Health Awareness Month.
6 questions investors may have about Johnson & Johnson’s acquisition of Actelion
Joaquin Duato, Executive Vice President and Worldwide Chairman, Pharmaceuticals, shares how the transaction will help expand the company’s portfolio of transformational therapies.
The mind matters: This Johnson & Johnson researcher is on a mission to change how we treat mental illness
Husseini Manji, M.D., is working toward a world in which diseases like depression and schizophrenia are diagnosed quickly and handled without stigma. His team’s discoveries in the lab may just get us there.
“I have schizophrenia": What it’s really like to live with the mental illness
For Mental Health Awareness Month, Tanara, who was diagnosed at the age of 27, shares her very honest story of coping with the disease.
7 health advocates who are determined to change what it means to have a chronic illness
Living with a life-altering disease is undeniably challenging. But it can also be full of triumphs if you embrace one simple mantra: It’s just a bad day, not a bad life.
5 Things We Now Know About Autism
It’s a medical condition we’ve all heard of, but one that many of us may not fully understand. For National Autism Awareness Month, we talked to two leading autism experts to get the very latest facts—and dispel misconceptions.
The new Ebola clinical trial that’s focused on helping halt future outbreaks
A groundbreaking partnership between countries, health organizations and companies worldwide—including Johnson & Johnson—hopes to find the most promising vaccines to help protect people from the virus.
How a Johnson & Johnson Employee’s Health Scare Brought a Company Mission to Intercept Diseases to Life
When Cat Oyler discovered she’d been born with a heart condition that had gone un-diagnosed, it hit home for her just how important her work helping to prevent and intercept disease really was.
